Seeing Is Believing

Currently out of the existing stock ratings of John Walsh, 122 are a HOLD (34.86%), 207 are a BUY (59.14%), 21 are a SELL (6%).
Analyst John Walsh, carries an average stock price target met ratio of 65.96% that have a potential upside of 22.7% achieved within 344 days. Previously, John Walsh worked at CREDIT SUISSE, VERTICAL RESEARCH.
John Walsh’s has documented 717 price targets and ratings displayed on 42 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare, Utilities sectors.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.
Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Jul-2026
$170
$15.79 (10.24%)
$150
2 months 15 days ago
(24-Jul-2026)
2/6 (33.33%)
$17.18 (11.24%)
73
Hold Since 16-Sep-2020
$142
$2.29 (1.64%)
$139
4 months 6 days ago
(03-Jun-2026)
6/7 (85.71%)
$11.89 (9.14%)
249
Hold Since 01-Oct-2025
$161
$21.29 (15.24%)
$165
5 months 10 days ago
(29-Apr-2026)
29/37 (78.38%)
$23.63 (17.20%)
292
Hold Since 20-Apr-2026
$157
$17.29 (12.38%)
$175
5 months 19 days ago
(20-Apr-2026)
7/8 (87.5%)
$11.88 (8.19%)
492
Hold Since 10-Jul-2024
$155
$0.79 (0.51%)
$175
6 months 8 days ago
(01-Apr-2026)
20/21 (95.24%)
$11.94 (8.35%)
231